O

Organon & Co
D

OGN

15.280
USD
0.40
(2.65%)
Market Closed
Volume
108,928
EPS
7
Div Yield
7.33
P/E
3
Market Cap
3,935,194,010
Related Instruments
    FLOWUSD
    FLOWUSD
    0.03605
    (5.72%)
    0.66520 USD
    A
    AXS
    1.700
    (2.00%)
    86.790 USD
    E
    ENJ
    -0.010
    (-0.04%)
    23.140 USD
    S
    SAND
    -0.13500
    (-2.46%)
    5.36000 USD
    More
News

Title: Organon & Co

Sector: Healthcare
Industry: Drug Manufacturers - General
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.